{"id":184,"date":"2019-10-19T23:23:40","date_gmt":"2019-10-19T23:23:40","guid":{"rendered":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-13-beta-2-agonist\/"},"modified":"2021-12-07T11:10:41","modified_gmt":"2021-12-07T11:10:41","slug":"4-13-beta-2-agonist","status":"publish","type":"chapter","link":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-13-beta-2-agonist\/","title":{"raw":"4.13 Beta-2 Agonists","rendered":"4.13 Beta-2 Agonists"},"content":{"raw":"Albuterol is a Beta-2 agonist.\n\nMechanism of Action:<\/strong> Albuterol is a selective Beta-2 agonist primarily used to cause bronchodilation in the lungs. However, Beta-2 receptors in the heart can also be stimulated, causing cardiovascular side effects.\n\nIndications:<\/strong>\u00a0 Albuterol is commonly used to treat asthma and chronic obstructive pulmonary disease (COPD).\n\nNursing Considerations:<\/strong> Monitor respiratory rate, oxygen saturation, and lungs sounds before and after administration. If more than one inhalation is ordered, wait at least 2 minutes between inhalations. Use a spacer device to improve drug delivery, if appropriate.\n\nAdverse Effects:<\/strong> Albuterol can cause hypersensitivity or paradoxical bronchospasm.\u00a0 It can also produce a clinically significant cardiovascular effect in some patients by causing increased heart rate and blood pressure, which may require the drug to be discontinued.\n\nPatient Teaching & Education:\u00a0<\/strong>Patients should remain compliant with the medication dosing regimen.\u00a0 Individuals should contact their healthcare provider if they experience ongoing shortness of breath unrelieved with medication therapy.\u00a0 If using an inhaler, the patient should be sure to prime the inhaler prior to administering the dose of medication.\u00a0 The medication can cause an unusual taste in the mouth, so patients should rinse their mouth with water after each use.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\n\nNow let's take a closer look at the medication grid on albuterol in Table 4.13.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>.[\/footnote]<\/sup>\n\nTable 4.13 Albuterol Medication Grid\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Administration Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Beta-2 agonist<\/th>\nalbuterol<\/strong><\/a><\/td>\nIf more than 1 inhalation is ordered, wait at least 2 minutes between inhalations\n\nUse spacer device to improve drug delivery, if appropriate<\/td>\nBronchodilation in asthma or COPD<\/td>\nHypersensitivity\n\nCan cause paradoxical bronchospasm\n\nReport significantly increased heart rate and blood pressure, which may require the drug to be discontinued<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n ","rendered":"

Albuterol is a Beta-2 agonist.<\/p>\n

Mechanism of Action:<\/strong> Albuterol is a selective Beta-2 agonist primarily used to cause bronchodilation in the lungs. However, Beta-2 receptors in the heart can also be stimulated, causing cardiovascular side effects.<\/p>\n

Indications:<\/strong>\u00a0 Albuterol is commonly used to treat asthma and chronic obstructive pulmonary disease (COPD).<\/p>\n

Nursing Considerations:<\/strong> Monitor respiratory rate, oxygen saturation, and lungs sounds before and after administration. If more than one inhalation is ordered, wait at least 2 minutes between inhalations. Use a spacer device to improve drug delivery, if appropriate.<\/p>\n

Adverse Effects:<\/strong> Albuterol can cause hypersensitivity or paradoxical bronchospasm.\u00a0 It can also produce a clinically significant cardiovascular effect in some patients by causing increased heart rate and blood pressure, which may require the drug to be discontinued.<\/p>\n

Patient Teaching & Education:\u00a0<\/strong>Patients should remain compliant with the medication dosing regimen.\u00a0 Individuals should contact their healthcare provider if they experience ongoing shortness of breath unrelieved with medication therapy.\u00a0 If using an inhaler, the patient should be sure to prime the inhaler prior to administering the dose of medication.\u00a0 The medication can cause an unusual taste in the mouth, so patients should rinse their mouth with water after each use.[1]<\/sup><\/a><\/sup><\/p>\n

Now let’s take a closer look at the medication grid on albuterol in Table 4.13.[2]<\/sup><\/a><\/sup><\/p>\n

Table 4.13 Albuterol Medication Grid<\/p>\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Administration Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Beta-2 agonist<\/th>\nalbuterol<\/strong><\/a><\/td>\nIf more than 1 inhalation is ordered, wait at least 2 minutes between inhalations<\/p>\n

Use spacer device to improve drug delivery, if appropriate<\/td>\n

Bronchodilation in asthma or COPD<\/td>\nHypersensitivity<\/p>\n

Can cause paradoxical bronchospasm<\/p>\n

Report significantly increased heart rate and blood pressure, which may require the drug to be discontinued<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

  1. uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a> ↵<\/a><\/li>
  2. This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>. ↵<\/a><\/li><\/ol><\/div>","protected":false},"author":2,"menu_order":13,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":"cc-by"},"chapter-type":[49],"contributor":[],"license":[53],"class_list":["post-184","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","license-cc-by"],"part":149,"_links":{"self":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/184\/revisions"}],"predecessor-version":[{"id":185,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/184\/revisions\/185"}],"part":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/149"}],"metadata":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/184\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=184"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=184"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=184"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}